Surgery Grand Rounds and Case Conference
February 12, 2014
Duke North – Room 2002
Surgical Grand Rounds
7:00 – 8:00 a.m.
“Update of Clinical Research Programs in the
Department of Surgery and the
School of Medicine”
Jeffrey Lawson, M.D., Ph.D.
Professor of Surgery
Professor in Pathology
Division of Vascular Surgery
Department of Surgery
Mark Stacy, M.D.
Vice Dean for Clinic Research, School of Medicine
Professor and Chair, Department of Neurology
Director, Site-Based Research
Surgical Case Conference
8:00 – 9:00 a.m.
Moderator: Bryan Clary, M.D.
Presenter Disclosure of Financial Relationships: Dr. Lawson discloses that he is a Principal Investigator for Baxter, Humacyte, and Proteon; a Consultant for Cryolife and Hemosphere; and a Speaker for W. L. Gore, but indicates no financial relationships relative to the content presented. Dr. Stacy discloses that he is a Consultant for Allergan, Avanir, Chelsea Therapeutics, EMD-Serono, GlaxoSmithKline, Medtronic, Neuronova, Novartis, Noven, Osmotica, Synosia, TEVA, Upsher-Smith, Eli Lilly, Pfizer, Avid, Merz, ProStraken, SK Life Sciences and UCB; Principal Investigator for Ceregene, ISCO, Michael J. Fox Foundation, NIH, and Parkinson Study Group; receives income from Wearing Off Questionnaire (WOQ) licensing agreement; Author for Informa Press for Handbook of Dystonia; and on the Protocol Steering Committee for Allergan (CD-PROBE). Dr. Clary indicates he has no financial relationships relative to the content presented and no personal/financial relationships to disclose which are relative to this activity.
RSS Activity Medical Director(s) Disclosure: Dr. Ranjan Sudan indicates he is a speaker for CineMed, but has no financial relationships relative to the content presented and no personal/financial relationships to disclose which are relative to this activity.
---Global Learning Objectives---
- Review and discuss new advances in general surgery;
- Present and discuss case studies, protocols, treatment guidelines and surgical/pathology report appropriate to General Surgery practice;
- Review and discuss clinical research findings and other evidence from pertinent literature.
The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
---Unapproved Use Disclosure---
Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (Not FDA approved) ; and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and /or unsupported opinion. Faculty at this event may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education, and is not intended to promote off-label use of these medications. If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
The Duke University School Of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in this activity.
In order to receive Credit, learners must sign in at the beginning of this event.
- 2.00 AMA PRA Category 1 Credit(s)™